Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Tuesday - 7 November 2023

Tuesday, 7 November 2023

Questions (1312, 1313, 1314)

Violet-Anne Wynne

Question:

1312. Deputy Violet-Anne Wynne asked the Minister for Health if he will provide an update on a review (details supplied); and if he will make a statement on the matter. [48564/23]

View answer

Violet-Anne Wynne

Question:

1313. Deputy Violet-Anne Wynne asked the Minister for Health if he plans to expand a scheme (details supplied) to people with endometriosis or chronic pain; and if he will make a statement on the matter. [48565/23]

View answer

Violet-Anne Wynne

Question:

1314. Deputy Violet-Anne Wynne asked the Minister for Health the number of consultants who work with patients on a scheme (details supplied); how many patients on that scheme they have under their care; and if he will make a statement on the matter. [48566/23]

View answer

Written answers

I propose to take Questions Nos. 1312 to 1314, inclusive, together.

The MCAP is currently undergoing an evidence synthesis review in relation as to whether evidence exists to expand the number conditions covered by the programme. This work has been undertaken by the Health Research Board on behalf of the Department of Health. The evidence synthesis review will be peer reviewed after which a clinical group will review the evidence synthesis to ascertain whether evidence exists to expand the scope of conditions covered by the programme. This is expected to be completed by end of 2023/early 2024.

To date, 14 consultants have made applications to be entered on the Cannabis for Medical Use Register for the treatment of 50 patients.

Question No. 1313 answered with Question No. 1312.
Question No. 1314 answered with Question No. 1312.
Top
Share